Abilify and Aggrenox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Aggrenox (aspirin; dipyridamole). Common drug interactions include death among females and upper gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Aggrenox. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Aggrenox?

Aggrenox has active ingredients of aspirin; dipyridamole. It is often used in stroke. eHealthMe is studying from 7,654 Aggrenox users. Check the latest studies of Aggrenox.

On Jul, 15, 2026

43 people who take Abilify and Aggrenox together, and have interactions are studied.

What are the common drug interactions of Abilify and Aggrenox, by gender? *:

female:

Death
Intussusception
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic kidney disease
Constipation
Cough
Dehydration (dryness resulting from the removal of water)
Dry eye (lack of adequate tears)
Eyelid margin crusting (crusting at the lid margins, generally worse on waking)
Gastrointestinal disorder (functional problems of gastrointestinal tract)

male:

Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Abnormal dreams
Ileus (a painful obstruction of the ileum or other part of the intestine)
Overdose
Pain
Psoriasis (immune-mediated disease that affects the skin)
Psychotic disorder
Thirst
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Abilify and Aggrenox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Hepatic enzyme increased
Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Restlessness (not able to rest)
Therapeutic response decreased (less preventive response)

50-59:

Blood pressure increased
Cholecystitis acute (rapid infection of gallbladder)
Death
Diabetic coma
Overdose
Sepsis syndrome (a clinical condition of blood infection)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Urinary tract infection

60+:

Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Intestinal resection
Intracranial aneurysm (bulging, weak area in the wall of a cranial artery)
Intussusception
Ocular hyperaemia (an abnormally large amount of blood in eye)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Polyuria (production of too much dilute urine)
Pyelonephritis (inflammation of kidney caused by bacteria)

What are the existing conditions these people have? *

High Blood Pressure: 16 people, 37.21%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 14 people, 32.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 32.56%
Back Pain: 13 people, 30.23%
Anaemia (lack of blood): 12 people, 27.91%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 12 people, 27.91%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 12 people, 27.91%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 12 people, 27.91%
Laryngitis (inflammation of the larynx): 12 people, 27.91%
Joint Pain: 12 people, 27.91%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Aggrenox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously